Metformin Hydrochloride Extended-Release Tablets
Metformin Hydrochloride Extended-Release Tablets is listed in the FDA National Drug Code directory with 8 NDC codes, marketed under brand name including Metformin Hydrochloride. Available dosage form: tablet, film coated, extended release.
Drug Details
- Generic Name
- Metformin Hydrochloride Extended-Release Tablets
- Brand Names
- Metformin Hydrochloride
- Application Number
- ANDA213334
- Sponsor
- ScieGen Pharmaceuticals, Inc.
- NDC Codes
- 8
- Dosage Forms
- TABLET, FILM COATED, EXTENDED RELEASE
- Routes
- ORAL
- Active Ingredients
- METFORMIN HYDROCHLORIDE
Indications and Usage
1 INDICATIONS AND USAGE Metformin hydrochloride extended-release tablet is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Metformin hydrochloride extended-release tablets is a biguanide indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. ( 1 )